POLYMORPHIC FORMS/HYDRATES OF N-[4-(3-CHLORO-4-FLUOROPHENYLAMINO)-7-(3-MORPHOLIN-4-YLPROPOXY)-QUINAZOLIN-6-YL]-ACRYLAMIDE DIHYDROCHLORIDE

There are described polymorphic forms/hydrates of N-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride, processes for their preparation, as well as the use of the same for the preparation of medicaments with irreversible tyrosine kinase inhibiti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: STEINER, KLAUS, HUELS, DIETMAR, WESTERMAYER, MANFRED, BARTH, HUBERT, SCHNEIDER, SIMON, MUEHLENFELD, ANDREAS
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator STEINER, KLAUS
HUELS, DIETMAR
WESTERMAYER, MANFRED
BARTH, HUBERT
SCHNEIDER, SIMON
MUEHLENFELD, ANDREAS
description There are described polymorphic forms/hydrates of N-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride, processes for their preparation, as well as the use of the same for the preparation of medicaments with irreversible tyrosine kinase inhibiting action. L'invention concerne des formes polymorphes/hydrates de N-[4-(3-chloro-4-fluorophénylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochlorure, des procédés de leur préparation, ainsi que leurs utilisations dans la préparation de médicaments à action inhibitrice irréversible de la tyrosine kinase.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO0200630A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO0200630A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO0200630A13</originalsourceid><addsrcrecordid>eNqNjUEOgjAURNm4MOodupTFj1UIrhsoaZPSjwWi1RhCTF0ZJcFLeGsL8QCu5s_k_Zl58ClR2QJNKWRKcjRFtRE2M6zmFcGcaLjEsI4gFQoNQgy5avxRCq6tYoXUGMJ-BKYKVFJ7xqrSI3iyIRwaqdl5yhOfX4GlZnrMOMnkuIRTtffLYHbvHoNb_XQRkJzXqQDXv1o39N3NPd27PSLdUZpElG2jP5AvOkM-iQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>POLYMORPHIC FORMS/HYDRATES OF N-[4-(3-CHLORO-4-FLUOROPHENYLAMINO)-7-(3-MORPHOLIN-4-YLPROPOXY)-QUINAZOLIN-6-YL]-ACRYLAMIDE DIHYDROCHLORIDE</title><source>esp@cenet</source><creator>STEINER, KLAUS ; HUELS, DIETMAR ; WESTERMAYER, MANFRED ; BARTH, HUBERT ; SCHNEIDER, SIMON ; MUEHLENFELD, ANDREAS</creator><creatorcontrib>STEINER, KLAUS ; HUELS, DIETMAR ; WESTERMAYER, MANFRED ; BARTH, HUBERT ; SCHNEIDER, SIMON ; MUEHLENFELD, ANDREAS</creatorcontrib><description>There are described polymorphic forms/hydrates of N-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride, processes for their preparation, as well as the use of the same for the preparation of medicaments with irreversible tyrosine kinase inhibiting action. L'invention concerne des formes polymorphes/hydrates de N-[4-(3-chloro-4-fluorophénylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochlorure, des procédés de leur préparation, ainsi que leurs utilisations dans la préparation de médicaments à action inhibitrice irréversible de la tyrosine kinase.</description><edition>7</edition><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20020103&amp;DB=EPODOC&amp;CC=WO&amp;NR=0200630A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20020103&amp;DB=EPODOC&amp;CC=WO&amp;NR=0200630A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>STEINER, KLAUS</creatorcontrib><creatorcontrib>HUELS, DIETMAR</creatorcontrib><creatorcontrib>WESTERMAYER, MANFRED</creatorcontrib><creatorcontrib>BARTH, HUBERT</creatorcontrib><creatorcontrib>SCHNEIDER, SIMON</creatorcontrib><creatorcontrib>MUEHLENFELD, ANDREAS</creatorcontrib><title>POLYMORPHIC FORMS/HYDRATES OF N-[4-(3-CHLORO-4-FLUOROPHENYLAMINO)-7-(3-MORPHOLIN-4-YLPROPOXY)-QUINAZOLIN-6-YL]-ACRYLAMIDE DIHYDROCHLORIDE</title><description>There are described polymorphic forms/hydrates of N-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride, processes for their preparation, as well as the use of the same for the preparation of medicaments with irreversible tyrosine kinase inhibiting action. L'invention concerne des formes polymorphes/hydrates de N-[4-(3-chloro-4-fluorophénylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochlorure, des procédés de leur préparation, ainsi que leurs utilisations dans la préparation de médicaments à action inhibitrice irréversible de la tyrosine kinase.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjUEOgjAURNm4MOodupTFj1UIrhsoaZPSjwWi1RhCTF0ZJcFLeGsL8QCu5s_k_Zl58ClR2QJNKWRKcjRFtRE2M6zmFcGcaLjEsI4gFQoNQgy5avxRCq6tYoXUGMJ-BKYKVFJ7xqrSI3iyIRwaqdl5yhOfX4GlZnrMOMnkuIRTtffLYHbvHoNb_XQRkJzXqQDXv1o39N3NPd27PSLdUZpElG2jP5AvOkM-iQ</recordid><startdate>20020103</startdate><enddate>20020103</enddate><creator>STEINER, KLAUS</creator><creator>HUELS, DIETMAR</creator><creator>WESTERMAYER, MANFRED</creator><creator>BARTH, HUBERT</creator><creator>SCHNEIDER, SIMON</creator><creator>MUEHLENFELD, ANDREAS</creator><scope>EVB</scope></search><sort><creationdate>20020103</creationdate><title>POLYMORPHIC FORMS/HYDRATES OF N-[4-(3-CHLORO-4-FLUOROPHENYLAMINO)-7-(3-MORPHOLIN-4-YLPROPOXY)-QUINAZOLIN-6-YL]-ACRYLAMIDE DIHYDROCHLORIDE</title><author>STEINER, KLAUS ; HUELS, DIETMAR ; WESTERMAYER, MANFRED ; BARTH, HUBERT ; SCHNEIDER, SIMON ; MUEHLENFELD, ANDREAS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO0200630A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2002</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>STEINER, KLAUS</creatorcontrib><creatorcontrib>HUELS, DIETMAR</creatorcontrib><creatorcontrib>WESTERMAYER, MANFRED</creatorcontrib><creatorcontrib>BARTH, HUBERT</creatorcontrib><creatorcontrib>SCHNEIDER, SIMON</creatorcontrib><creatorcontrib>MUEHLENFELD, ANDREAS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>STEINER, KLAUS</au><au>HUELS, DIETMAR</au><au>WESTERMAYER, MANFRED</au><au>BARTH, HUBERT</au><au>SCHNEIDER, SIMON</au><au>MUEHLENFELD, ANDREAS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>POLYMORPHIC FORMS/HYDRATES OF N-[4-(3-CHLORO-4-FLUOROPHENYLAMINO)-7-(3-MORPHOLIN-4-YLPROPOXY)-QUINAZOLIN-6-YL]-ACRYLAMIDE DIHYDROCHLORIDE</title><date>2002-01-03</date><risdate>2002</risdate><abstract>There are described polymorphic forms/hydrates of N-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride, processes for their preparation, as well as the use of the same for the preparation of medicaments with irreversible tyrosine kinase inhibiting action. L'invention concerne des formes polymorphes/hydrates de N-[4-(3-chloro-4-fluorophénylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochlorure, des procédés de leur préparation, ainsi que leurs utilisations dans la préparation de médicaments à action inhibitrice irréversible de la tyrosine kinase.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO0200630A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title POLYMORPHIC FORMS/HYDRATES OF N-[4-(3-CHLORO-4-FLUOROPHENYLAMINO)-7-(3-MORPHOLIN-4-YLPROPOXY)-QUINAZOLIN-6-YL]-ACRYLAMIDE DIHYDROCHLORIDE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T22%3A29%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=STEINER,%20KLAUS&rft.date=2002-01-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO0200630A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true